Conversely, albumin levels were consistently reduced in both the pregestational and insulin-treated gestational diabetes groups, likely reflecting a hepatic shift toward increased synthesis of acute-phase reactants, such as CRP and fibrinogen, as part of the systemic inflammatory response associated with impaired glycemic control. The gene discussed is INS; the disease is gestational diabetes.